Last updated: June 8, 2026, 11:33 PM ET

Public Markets Briefing

Geopolitical Tensions & Energy Markets

Oil edged higher in early trade amid ongoing supply disruption concerns, with prices picking up after Iran and Israel exchanged strikes that threatened to derail regional peace efforts. The commodity settled near previous levels following reports that Israel and Iran agreed to end attacks against each other, easing concerns about wider Middle East conflict. Meanwhile, natural gas futures pulled back as weather forecasts shed some heat for the second half of June and LNG exports were held back by maintenance. Copper held gains from the previous session as tensions in the Middle East eased, though investors awaited trade data from China, the world's top metal consumer. The easing geopolitical tensions also supported energy shares as US stocks rebounded from last week's slump.

AI & Tech Sector Developments

The artificial intelligence sector saw significant developments as Apple unveiled a new AI-powered version of its Siri digital assistant, promising user privacy in its long-delayed overhaul. Meanwhile, OpenAI filed for an IPO expected to value the Chat GPT creator at more than $1 trillion, joining a rush of AI companies tapping public markets. The company submitted paperwork confidentially for the highly anticipated offering that could unlock a new generation of tech industry wealth. This AI bonanza has Wall Street rushing to fund the sector in every conceivable way, from giant debt deals to IPOs. SpaceX's IPO is also progressing, with the offering well oversubscribed with multiple institutional investors placing orders for about $10 billion or more of shares as Elon Musk shows detailed design of AI data center satellites.

Market Performance

Global markets showed resilience despite recent volatility, with Asian stocks recovering after their biggest drop since March as tensions in the Middle East eased and a selloff in artificial intelligence shares abated. In the US, stocks closed mostly higher, led by the Nasdaq composite, as tech stocks made up some ground and Iran and Israel paused renewed strikes. Chip stocks led a market rebound as semiconductor companies benefited from renewed investor interest in the AI sector. JPMorgan's trading desk took a cautious view toward US stocks following the selloff that erupted at the end of last week, though some Wall Street strategists see the rally intact after what they consider a healthy tech drop, saying earnings growth should support stocks through the end of the year.

Currency & Fixed Income Markets

The Singapore dollar edged higher against its U.S. counterpart amid mild risk-on sentiment spurred by easing Middle East tensions. In contrast, the WSJ Dollar Index fell 0.1% — down two of the past three trading days as the greenback weakened against major currencies. In fixed income, municipal bonds show potential for a solid second half as attractive yields and strong credit fundamentals support the market, said Vanguard's Paul Malloy. Meanwhile, Amazon.com raised C$14 billion in a record Canadian dollar bond sale, the largest corporate debt offering on record in the currency, after drawing about twice that amount in demand. Private credit performance defies media gloom as institutional investors show faith in the asset class since default rates in portfolios remain low, according to Arcmont CEO Anthony Fobel.

M&A Activity

The pharmaceutical sector saw a major potential deal as GSK entered talks to buy cancer biotech Nuvalent for more than $9 billion, which would rank as one of the UK drugmaker's biggest acquisitions as biotech M&A activity accelerates this year. The discussions reportedly value Nuvalent between $9 billion and $10 billion according to the Financial Times. In private equity, Bain Capital made a non-binding bid for Australia's oOh!Media Group, joining other bidders for the outdoor advertising company. In a significant financing deal, Apollo and Blackstone raised $35 billion in chip financing for Anthropic, one of the largest private credit fundraisings to fuel the Claude maker's AI growth plans. Elsewhere, Roche licensed Nurix Therapeutics' blood-cancer drug for up to $2.3 billion, paying $700 million upfront while development costs would be split 60-40, with Roche taking the larger share. Incyte struck up to a $2 billion deal for blood disorder biotech Vega Therapeutics, expanding the company's hematology portfolio.

Specialty Sectors

Brazilian stocks face headwinds as investors are advised to get pickier with Brazil stocks as economic growth is set to cool and the nation heads toward a polarized presidential vote, according to XP Inc. In the rare earth sector, Brazil is positioning itself as a potential alternative to China's dominance, holding the world's second-largest rare-earth reserves and wanting to become a processor of critical minerals while refusing to choose sides between Washington and Beijing. The airline industry continues to face challenges with West Jet slamming Canada's loan offer to airlines hit by fuel costs in the wake of the closing of the Strait of Hormuz. Meanwhile, Vail Resorts cut its outlook again as low snowfall weighed on visits during the recent quarter, with weather conditions remaining extremely unfavorable, particularly at the company's resorts in the Rockies.